Patents
Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798)
12/2005
12/28/2005EP1326643B1 Inhibition of emetic effect of metformin with 5-ht3 receptor antagonists
12/28/2005EP1235565B1 Use of 5ht 3 agonists for relaxing the fundus
12/28/2005EP1021204B1 Bioadhesive compositions and methods for topical administration of active agents
12/28/2005EP0991660B1 DEUTERATED and undeuterated CYCLOSPORINE ANALOGS AND THEIR USE AS IMMUNOMODULATING AGENTS
12/28/2005EP0945445B9 1,5-benzodiazepine derivatives
12/28/2005CN1714096A Mmp inhibitors
12/28/2005CN1714084A Pyrimidine-2,4,6-trione metalloproteinase inhibitors
12/28/2005CN1713906A Treatment of gastrointestinal disorders with duloxetine
12/28/2005CN1713901A Hydroxypropylmethylcellulose capsule preparation having teprenone encapsulated therein
12/28/2005CN1713894A Method for preparing a compound of interaction of active substances with a porous support using supercritical fluid
12/28/2005CN1713861A Vascularization enhanced graft constructs
12/28/2005CN1233839C Productive method of recombinant human liver regenerated enhanced factor
12/28/2005CN1233823C Antigen-sensitive human GM-CSF gene modified human dendritic cell and its preparing process and usage
12/28/2005CN1233663C Preparation of carboxymethyl chitin bismuth and its application in treating gastritis and gastrelcoma
12/28/2005CN1233643C Ramification of a compound of medication as well as preparation method and application
12/28/2005CN1233416C Compound pepsin powder for treating child dyspepsia and its preparation method
12/28/2005CN1233409C Combination of Chinese traditional medicine for health preservation and preparation method
12/28/2005CN1233407C Mixture of aucklandia root and garden burnet for easing stomach and its preparation
12/28/2005CN1233406C Prescription for treating cholecystolithiasis
12/28/2005CN1233401C Agastache capsule for restoring healthy energy and its preparation
12/28/2005CN1233399C Effervescence tablet of radix isatidis and its preparation
12/28/2005CN1233398C Medicine for treating stomatocace
12/28/2005CN1233388C Medicinal composition for treating hepatitis
12/28/2005CN1233371C Quick effect toothache plaster
12/28/2005CN1233368C Medicine for treating chronic diarrhea
12/28/2005CN1233364C Chinese medicine for treating digestive ulcerating sore and its preparation method
12/28/2005CN1233359C Compound capsule of chicken-bone herb and its prodn. method
12/28/2005CN1233357C Insect-ant capsule
12/28/2005CN1233356C Method for preparing 'Yueju' capsule
12/28/2005CN1233352C Hepatosis treating medicine
12/28/2005CN1233349C Heat-clearing, toxin-expelling, swell-subsiding Chinese medicinal composition and its use
12/28/2005CN1233345C Chinese proprietary drug for treating cholelithiasis
12/28/2005CN1233339C Powdered medicine for treating viral hepatitis B
12/28/2005CN1233338C Mark-removing capsule
12/28/2005CN1233318C Hepadestal soft capsule and its preparing method
12/28/2005CN1233317C Milk thistle silybum marianum self-emulsified micro-emulsion composition and its preparation process
12/28/2005CN1233257C A composition containing carvacrol and thymol for use as abactericide
12/27/2005US6979694 Drugs such as (5-(((2,4,6-Trimethylphenyl)amino)carbonyl)-4-methyl-2-thiazolyl)carbamic acid, 1,1-dimethylethyl ester, used as enzyme inhibitors, for prohylaxis of inflammatory bowel disease; modulation of immunology
12/27/2005US6979691 Compounds useful as modulators of melanocortin receptors and pharmaceutical compositions comprising same
12/27/2005US6979690 Oxo or oxy-pyridine compounds as 5-HT4 receptor modulators
12/27/2005US6979683 Polymerase enzyme inhibitors
12/27/2005US6979447 Immunomodulation and effect on cell processes relating to serotonin family receptors
12/27/2005CA2156287C Indolin-2-one derivative
12/22/2005WO2005121312A1 Selection and use of lactic acid bacteria for reducing dental caries and bacteria causing dental caries
12/22/2005WO2005121135A1 Vla-4 inhibitor
12/22/2005WO2005121123A1 Compounds as cor5 antagonists
12/22/2005WO2005120527A1 Use of lactic acid bacteria for decreasing gum bleeding and reducing oral inflammation
12/22/2005WO2005120491A1 Remedy or preventive for inflammatory bowel disease
12/22/2005WO2005120485A1 Regulator of physiological function of ghrelin and use thereof
12/22/2005WO2005120484A1 Regulator for physiological functions of ghrelin
12/22/2005WO2005120467A2 Dosage form containing the active ingredient cholylsarcosine
12/22/2005WO2005080397A3 Fused hetrocyclic compounds and their use as metabotropic receptor antagonists for the treatment of gastrointestinal disorders
12/22/2005WO2004093823A3 Polyethelene glycol link glp-1 compounds
12/22/2005WO2003057856A3 Dominant negative proteins and methods thereof
12/22/2005US20050283844 Multipotent adult stem cells, sources thereof, methods of obtaining and maintaining same, methods of differentiation thereof, methods of use thereof and cells derived thereof
12/22/2005US20050282900 Inhibitors of alpha4 mediated cell adhesion
12/22/2005US20050282889 Intracorporeal medicaments for photodynamic treatment of disease
12/22/2005US20050282882 Diamines as modulators of chemokine receptor activity
12/22/2005US20050282881 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
12/22/2005US20050282875 Pyrrolidinium derivatives
12/22/2005US20050282867 Hydrochloride salt of 5-[4-[2-(N-methyl-N-(2-pyridyl)amino)ethoxy]benzyl]thiazo-lidine-2,4-dione
12/22/2005US20050282866 2,3-Diphenyl-1H-indole-5-carboxylic acid; I kappa B kinase inhibitor; decrease activation of nuclear factor (NF) kappa B; antiinflammatory agent: arthritis, osteoarthritis, asthma, cardiac infarct, Alzheimer's disease, carcinomateous disorders or atherosclerosis
12/22/2005US20050282861 Sulfonamide-containing benzene derivatives; cancer and inflammatory, immunomodulatory or respiratory diseases; allergy, seasonal allergic rhinitis, reversible airway obstruction, adult respiratory distress syndrome, asthma, or bronchitis
12/22/2005US20050282852 Preventive and therapeutic medicament for gastroesophageal reflux disease
12/22/2005US20050282817 4-(3-Phenyl-3-carbocycloylpropyl)-1-phenyl- or pyridylpiperazine derivatives: 1-(2-methoxyphenyl)-4-[3-(benzoyl)-3-(phenyl)propyl]piperazine oxalate; serotonin receptor antagonists; obesity
12/22/2005US20050282798 Pharmaceutical compounds
12/22/2005US20050282789 administering for treatment of metabolic bone diseases, mobilizing calcium for osteoporosis, imbalances in the immune system
12/22/2005US20050282786 Method for reducing c-rective protein levels with non-antibacterial tetracycline formulations
12/22/2005US20050282746 DNA encoding the receptor, a transformed cell expressing the receptor, producing the receptor by culturing the transformed cells; receptor binding assays; drug screening for agonists, antagonists, or allosteric modulators
12/22/2005US20050282255 Cell growth differentiation factor (MP52) for use in treatment and prevention of nervous system, dental, skin, connective tissue and bone disorders; wound healing agents
12/22/2005US20050282236 Inhibitors of macrophage migration inhibitory factor and methods for identifying the same
12/22/2005US20050282165 Diagnosis of Carcinoma Using RAIG1 Polypeptides
12/22/2005US20050281910 Method for increasing pet activity
12/22/2005US20050281885 Method for treating inflammatory bowel disease by oral administration of IL-10
12/22/2005US20050281818 Method for the treatment of fibrosis
12/22/2005US20050281794 comprising a catechin (epigallocatechin gallate), an anti-oxidant (ascorbic acid), proline and lysine; cancer
12/22/2005US20050281756 Use of lactic acid bacteria for decreasing gum bleeding and reducing oral inflammation
12/22/2005DE20023736U1 Compositions comprising American ginseng and/or its extract for the prevention and treatment of gastro-duodenal ulcers
12/22/2005CA2569678A1 Regulator of physiological function of ghrelin and use thereof
12/22/2005CA2567063A1 Dosage form containing the active ingredient cholylsarcosine
12/21/2005EP1607395A1 Process for production of sulfoxide derivatives or salts thereof in the amorphous state
12/21/2005EP1607394A1 Water-soluble thalidomine derivatives
12/21/2005EP1607387A2 3,4,4-trisubstituted piperidine derivatives and their use as opioid antagonists
12/21/2005EP1607103A1 Concomitant drug as therapeutic agent for inflammatory bowel disease
12/21/2005EP1607101A1 Degradation inhibitor for hepatitis b virus x interacting protein
12/21/2005EP1607091A1 Antihepatitis c virus agent and anti-hiv agent
12/21/2005EP1607090A1 Asimadoline for the treatment of irritable bowel syndrome
12/21/2005EP1607088A1 Controlled release composition
12/21/2005EP1607087A1 Medicinal oral preparations for colon delivery, medicinal oral preparations for treating colon cancer and medicinal oral preparations for treating colitis
12/21/2005EP1606630A2 Diagnostics and therapeutics for diseases associated with dopamine receptor d4 (drd4)
12/21/2005EP1606279A1 Polymorphs of s-omeprazole
12/21/2005EP1605975A1 Composition and method for the treatment and prevention of enteric bacterial infections
12/21/2005EP1605926A1 Use of pinitol or chiroinositol for protecting the liver
12/21/2005EP1605897A2 Polyethelene glycol link glp-1 compounds
12/21/2005EP1576086A3 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
12/21/2005EP1468075B1 Novel lactobacillus sp. strain and use thereof
12/21/2005EP1458723A4 Fused heterocyclic succinimidecompounds and analogs thereof, modulators of nuclear hormone receptor function
12/21/2005EP1432701B1 Heterocyclic compounds for use in the treatment of disorders of the urinary tract
12/21/2005EP1395558B1 4-(phenyl-(piperidin-4-yl)-amino)-benzamide derivatives and their use for the treatment of pain, anxiety or gastrointestinal disorders
12/21/2005EP1395555B1 4-(phenyl-(piperidin-4-yl)-amino)-benzamide derativatives and their use for the treatment of pain, anxiety or gastrointestinal disorders